PTH and osteoporosis: The other recent report using TriNetX (a global federated health research network with real-time electronic medical records from 113 medical facilities from 16 countries at the time of analysis) enrolled patients aged ≥ 40 years, with a diagnosis of osteoporosis and a prescription of romosozumab or a PTH analog (teriparatide/abaloparatide) between August 2019 and August 2022.